Researchers at Columbia University have used base editing to modify human embryo DNA with unprecedented precision, bypassing the risks of traditional CRISPR.
The NIAID, once led by Anthony Fauci, faces a critical leadership void as new Ebola outbreaks emerge, raising questions about the US's readiness for the next pandemic.
New clinical trial data reveals a personalized mRNA vaccine from Moderna significantly reduces the risk of melanoma returning and metastasizing over five years.
Samsung and Massachusetts General Hospital are investigating if wearable body composition data can prevent lean muscle wasting in patients using Ozempic and Wegovy.
Samsung and Massachusetts General Hospital are testing if Galaxy Watch body composition data can help patients prevent lean muscle loss during GLP-1 weight loss treatments.
Interim data from the VERVE-102 trial shows a significant drop in LDL cholesterol via base-editing, potentially replacing lifelong statin use.
Researchers from the University of York and University of Copenhagen have identified the genes and enzymes responsible for nicotine production, opening doors for cleaner pharmaceutical manufacturing.